Philab Holdings reported earnings results for the first nine months of 2018. The company announced that it booked a net loss attributable to the parent of PHP 107.85 million in the first nine months of 2018, compared to an attributable loss of PHP 860,006 in the same period a year ago. The company managed to book gross revenues of PHP 155.15 million during the nine-month period.

The company targets to return to profitability in 2019, banking on the wider distribution of its dengue testing kits coupled by higher revenues from its medical laboratory business.